Global Intravenous (IV) Therapy and Vein Access Market Set to Reach $54.5 Billion

December 31, 2018

WELLESLEY, Mass. Dec. 31, 2018 – The global market for intravenous (IV) therapy and vein access continuously evolving and is expected to see sustained growth over the next five years. This growth is a result of a growing aging population, persistent chronic conditions and lifestyle diseases, a balance of healthcare services between hospitals and more cost-effective sites and expanding product demands in developing markets, according to BCC Research.                                                                                                               

The global market for IV therapy and vein access was valued at $40.7 billion in 2018 and is expected to reach $54.5 billion by 2023 growing at a compound annual growth rate (CAGR) of 6.0%, according to the report “Intravenous (IV) Therapy and Vein Access: Global Markets.”

Prominent players in the industry include AngioDynamics (ANGO), B. Braun Melsungen AG, Baxter International (BAX), Becton Dickinson and Co. (CareFusion Corp., C. R. Bard) (BDX), Fresenius Kabi, ICU Medical, Inc. (Hospira) (ICUI), Medtronic (MDT), Smiths Group (Smiths Medical) (SMGKF), Teleflex (TFX), Insulet Corp. (PODD), Tandem Diabetes Care (TNDM), Nestlé Health Science and others.

Research Highlights:

  • In emerging markets, due to growing healthcare infrastructure and healthcare spending, the demand for IV therapy and vein access products has increased considerably, which will further drive future market growth.
  • Within the IV therapy and vein access market, the home-based care setting is the fastest growing market globally, driven by the rise of patients suffering from chronic ailments like cancer and AIDS.
  • North America holds a major share of the overall market due to factors such as higher numbers of chronic conditions and lifestyle diseases, the aging population, a steady increase in surgical procedural volumes, proper regulatory policies and more.  

“The modern infusion therapy market is moving toward a wireless, integrated technology system that ultimately helps caregivers achieve 100% drug library compliance, minimize medication errors and reduce alarms and alerts,” the report notes.

Factors Restraining the Global IV Therapy and Vein Access Market

While there are many driving growth factors in the market, factors restraining market growth include: health care reforms and budgetary constraints in developed countries, reimbursement policies, regulatory issues, manufacturing issues and recalls.

Editors/reporters requesting analyst interviews should contact Eric Surber at

Intravenous (IV) Therapy and Vein Access: Global Markets( HLC046E )
Publish Date: Dec 2018    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email or visit to request access to our library of market research.